Observational study: Temporal dynamics of lipoprotein(a) after out-of-hospital cardiac arrest: The Biobank Working
Daniel Kogler1, Christian Schoergenhofer2, Alexandra Lipa1
1Department of Emergency Medicine, Medical University of Vienna, Austria.
Background:
Out-of-hospital cardiac arrest (OHCA) is a major cause of death in the USA and Europe, with survival rates around 10%. Lipoprotein(a) [Lp(a)] is an established cardiovascular risk factor, but its temporal profile following OHCA is unknown.
Methods:
In this retrospective study at a tertiary cardiac arrest center, 50 adult patients with OHCA of presumed cardiac origin were included and stratified by 6-month neurological outcome (CPC 1-2 vs. CPC 3-5). Longitudinal Lp(a) concentrations were analyzed using a linear mixed-effects model with fixed effects for time point, neurological outcome, and their interaction. Exploratory logistic regression assessed associations between Lp(a) at ROSC and neurological outcome.
Results:
26 patients had a favorable outcome, and 22 had an unfavorable outcome (two patients were excluded after analysis due to problems with the sample). Baseline characteristics were similar, except for longer low-flow duration (p = 0.005), higher cummulative epinephrine dosage (p = 0.025) and lower pH (p = 0.013) in the unfavorable group. Absolute Lp(a) concentrations at ROSC did not differ between groups (p = 0.646) and were not associated with outcome. In the mixed-effects model, both timepoint (p < 0.0001) and the timepoint × outcome interaction (p = 0.020) were significantly associated with Lp(a) concentrations. Lp(a) remained relatively stable in patients with a favorable outcome, whereas it declined significantly over 48 h in those with an unfavorable outcome.
Conclusion:
Lp(a) exhibits a time-dependent trajectory after OHCA that differs by neurological outcome. While baseline levels are not predictive, patients with unfavorable outcomes show a significant decline over time, suggesting a dynamic response possibly linked to disease severity.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
